ASTRAZEN — Astrazeneca Pharma India Share News
0.000.00%
Last trade - 00:00- IN₹149.71bn
- IN₹146.34bn
- IN₹22.76bn
Brief: Astrazeneca Pharma India Sept-Quarter PAT Rises
Receives Import And Market Permission In Form Ct-20 From Drugs Controller General Of India For Olaparib
Brief: Astrazeneca Pharma India Ltd March-Quarter PAT 279.8 Million
India considers widening COVID booster effort to all adults, sources say (updated)
Brief: Astrazeneca Pharma India Dec-Qtr PAT Falls
Media: AstraZeneca Pharma India working on vaccine to prevent and cure COVID - ET
Iran's daily COVID-19 deaths hit record high of 655
Brief: Astrazeneca Pharma India June-Quarter PAT Falls
Refinitiv Newscasts - Asia Insight: Indian shares steady ahead of cabinet reshuffle
Brief: Astrazeneca Pharma India Gets Notice Of Demand From National Pharmaceutical Pricing Authority
Brief: Astrazeneca Pharma India Terminates Distribution Agreement For Dapagliflozin With Abbott Healthcare
Brief: Astrazeneca Pharma India, Sun Pharma Enter Into Transition Supply Agreement For Dapagliflozin
Brief: Astrazeneca Pharma India March-Qtr PAT Rises
EU wants AstraZeneca to deliver 120 mln COVID vaccines by end-June
Five EU countries say focus should be on vaccine production, not patents (updated)
Brief: Astrazeneca Pharma India Gets Import, Market Permission From DCGI For Osimertinib Film Coated Tablets
EU's von der Leyen tells skittish Europeans: 'I'd take AstraZeneca vaccine'
Brief: Astrazeneca Pharma India Dec-Quarter PAT Falls
Michel says EU should consider legal means to secure promised vaccines